A proposed business-supremacy treaty for Asia includes restrictions on generic medicines, and would stop India from providing many generic drugs to poor people in a number of other countries.

As with other business-supremacy treaties, often referred to misleadingly as "free trade treaties" by their supporters, there is no good in this treaty. The countries involved should kill it.

It is a fundamental mistake to call these restrictions "intellectual property" because that leads people to confuse them with unrelated issues such as copyright law. Every time that term is used, it spreads confusion — so please, don't use it!